The "NIH Reform Act" aims to significantly restructure a component of the National Institutes of Health by replacing the existing National Institute of Allergy and Infectious Diseases (NIAID). This legislation proposes to divide NIAID's broad responsibilities into three more specialized and independent research institutes. The primary objective is to create more focused entities dedicated to specific areas of health research, enhancing their individual missions. Specifically, the bill establishes the National Institute of Allergic Diseases , the National Institute of Infectious Diseases , and the National Institute of Immunologic Diseases . Each of these new institutes will be responsible for conducting and supporting research, training, and health information dissemination within its designated area. This includes transferring existing authorities and programs related to allergic, infectious, and immunologic diseases from the former NIAID to the appropriate new institute. The directors for these newly formed institutes will be appointed by the President, subject to the advice and consent of the Senate, and will serve for five-year terms, with eligibility for one reappointment. During the transition period, the Director of the National Institutes of Health will temporarily oversee the new institutes until their individual directors are officially appointed and confirmed, ensuring an orderly transfer of responsibilities.